Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 136 are a BUY (93.15%), 5 are a SELL (3.42%), 5 are a HOLD (3.42%).
Analyst Leland Gershell works at OPPENHEIMER with a stock forecast success ratio of 32.88% fulfilled within 120.38 days on average.
Leland Gershell’s has documented 328 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TARA, Protara Therapeutics at 22-Apr-2024.
Analyst best performing recommendations are on NCNA (NUCANA PLC).
The best stock recommendation documented was for NCNA (NUCANA PLC) at 4/1/2024. The price target of $4 was fulfilled within 10 days with a profit of $3.76 (1566.67%) receiving and performance score of 1566.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2.5
$-0.28 (-10.07%)
1 years 2 months 12 days ago
1/1 (100%)
$1.86 (290.63%)
145
Buy
30
1 years 10 months 5 days ago
0/1 (0%)
$22.32 (290.63%)
Buy
3 years 7 months 27 days ago
0/1 (0%)
$59.52 (163.16%)
Which stock is Leland Gershell is most bullish on?
Which stock is Leland Gershell is most reserved on?
What Year was the first public recommendation made by Leland Gershell?